Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Number of holders
-
128
-
Total 13F shares, excl. options
-
39,538,270
-
Shares change
-
+1,326,335
-
Total reported value, excl. options
-
$573,258,785
-
Value change
-
+$22,292,833
-
Put/Call ratio
-
87.84%
-
Number of buys
-
68
-
Number of sells
-
-57
-
Price
-
$14.5
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q3 2017
158 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q3 2017.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39,538,270 shares
of 119,358,581 outstanding shares and own 33.13% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6,845,900 shares), FMR LLC (4,489,946 shares), VANGUARD GROUP INC (3,387,871 shares), JANUS HENDERSON GROUP PLC (2,778,605 shares), LANSDOWNE PARTNERS (UK) LLP (2,647,981 shares), WELLINGTON MANAGEMENT GROUP LLP (2,320,797 shares), STATE STREET CORP (1,835,515 shares), CITADEL ADVISORS LLC (1,250,297 shares), BVF INC/IL (1,241,021 shares), and PINNACLE ASSOCIATES LTD (1,008,805 shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.